免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Scenaria View 4.2

K 號:K231574 · 2023-10-12

決定日期2023-10-12
產品代碼JAK
諮詢委員會RA
決定相當於

器材摘要

Scenaria View 4.2 is the device name listed in this FDA 510(k) record. The listed applicant is FUJIFILM Healthcare Americas Corporation. It received FDA 510(k) clearance on 2023-10-12 under 510(k) number K231574. The device is classified under product code JAK. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Scenaria View 4.2?

Scenaria View 4.2 is a medical device that received FDA 510(k) clearance on 2023-10-12. The listed applicant is FUJIFILM Healthcare Americas Corporation. The 510(k) number is K231574.

When did Scenaria View 4.2 receive FDA 510(k) clearance?

Scenaria View 4.2 received FDA 510(k) clearance on 2023-10-12, under 510(k) number K231574.

Who is the listed applicant for Scenaria View 4.2?

The FDA 510(k) record lists FUJIFILM Healthcare Americas Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Scenaria View 4.2?

The FDA product code for Scenaria View 4.2 is JAK.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 FUJIFILM Healthcare Americas Corporation 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 13 項裝置 →

相關器械(代碼:JAK)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑